Professor Nick Maskell

Nick Maskell leads the Bristol Academic Respiratory Unit, consisting of a large team that develops and then tests translational work, providing an evidence base for improvements to patient centred respiratory care. His current H-index is 74. He has a total grant income of £55 million as PI or Co-PI.

He has a major interest in pleural disease, running a tertiary pleural disease service and chairing the regional mesothelioma MDT. He chaired the existing British Thoracic Society (BTS) pleural disease guidelines (2023) and is an advisor to Royal college of Physicians on patient safety related to pleural interventions.

He is the Clinical Director of the Bristol NIHR- Biomedical Research centre (BRC) and leads the Respiratory Theme. He also co-leads the Pleural theme of the NIHR-Respiratory Translational Research Collaboration. He is an NIHR Senior Investigator.

Nick is the current President of the British Thoracic Society has had previous leading roles in both European Respiratory Society (ERS) American guideline groups. He is a regular international invited speaker, speaking in over 60 countries over the past decade. He has been made a Fellow of the American Society of Chest Physicians and Fellow of the ERS.

He has previously been the President of the West Country Chest Society, regional adviser for the Royal College of Physicians associate editor of Thorax. He is currently the Chair of Trustees for Mesothelioma UK and Bristol Health Research Charity.

He leads the largest academic pleural research centre in the UK and established the Pleural Investigation Study in 2008, which now holds over 30,000 serum and pleural fluid samples from around 3,000 prospectively collected patients, and is the largest repository of pleural samples in the world. This has enabled a broad range of research, including biomarker discovery and validation. In addition, he has led a number of phase I-III clinical trials in pleural disease, which have changed clinical practice.